Reporting owner · CIK 0001586788

Quisel John D

SEC Form 4 history across 2 companies, 9 transactions and 4 filings.

DIRGossamer Bio, Inc.
Open-market transaction mix0% buys0 buys · 3 sales

Available history · Jun 04, 2026 – Sep 23, 2026

Filings4Form 4 records
Buying$00 purchases
Selling$2.6M3 sales
Net value−$2.6MBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from available history.
Quisel John D transactions · 20 per page
CompanyInsiderActivityDisclosed valueFiled (ET)
GOSSGossamer Bio, Inc.
Quisel John DDIRA · grantDerivative securitySEC filing ↗$0View disclosure →
IRONDisc Medicine, Inc.
Quisel John DCEOM · exerciseDerivative securitySEC filing ↗$0View disclosure →
IRONDisc Medicine, Inc.
Quisel John DCEOM · exerciseSEC filing ↗$36.3kView disclosure →
IRONDisc Medicine, Inc.
Quisel John DCEOM · exercise10b5-1 detectedDerivative securitySEC filing ↗$0View disclosure →
IRONDisc Medicine, Inc.
Quisel John DCEOS · sale10b5-1 detectedSEC filing ↗-$949kView disclosure →
IRONDisc Medicine, Inc.
Quisel John DCEOS · sale10b5-1 detectedSEC filing ↗-$1.00MView disclosure →
IRONDisc Medicine, Inc.
Quisel John DCEOS · sale10b5-1 detectedSEC filing ↗-$656kView disclosure →
IRONDisc Medicine, Inc.
Quisel John DCEOM · exercise10b5-1 detectedSEC filing ↗$445kView disclosure →
GOSSGossamer Bio, Inc.
Quisel John DDIRA · grantDerivative securitySEC filing ↗$0View disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

sale at Disc Medicine, Inc. on Aug 17, 2026 valued at $949,162.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Disc Medicine, Inc. on Aug 17, 2026 valued at $949,162.

Review SEC filing

Monthly open-market activity

Last 3 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Jun 202600$0.00$0.00$0.00
Aug 202603$0.00$2,611,982.32-$2,611,982.32
Sep 202600$0.00$0.00$0.00

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$870.7K
Median P/S size$949.2K
Direct9
Indirect0
Sep 23, 2026grant

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in available history

A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

5 observations · Aug 17, 2026 – Sep 15, 2026. Window ends at the latest available report, not today.

Selected observation · Sep 15, 2026262,064 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Aug 17, 2026259,064Aug 18, 2026View transaction
Aug 17, 2026250,664Aug 18, 2026View transaction
Aug 17, 2026237,952Aug 18, 2026View transaction
Aug 17, 2026226,064Aug 18, 2026View transaction
Sep 15, 2026262,064Sep 16, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Quisel John D Insider Activity FAQ

SEC Form 4 context

Who is Quisel John D?

Quisel John D is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001586788.

Which companies has Quisel John D reported transactions for?

Gossamer Bio, Inc., Disc Medicine, Inc.

When was Quisel John D's latest insider buy?

No open-market insider purchase is available for this period.

When was Quisel John D's latest insider sale?

sale at Disc Medicine, Inc. on Aug 17, 2026 valued at $949,162.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.